⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5060469 | 0.91 | — | — | |
| SCHEMBL11517646 | 0.83 | — | — | |
| SCHEMBL240790 | 0.80 | TSHR (0.40) | — | |
| SCHEMBL11516414 | 0.78 | ALDH1A1 (0.45) | — | |
| SCHEMBL10495272 | 0.71 | LDHA (0.42) | — | |
| SCHEMBL95725 | 0.68 | — | — | |
| SCHEMBL735578 | 0.67 | CAMK2A (0.42) | — | |
| SCHEMBL11162628 | 0.67 | — | — | |
| SCHEMBL7066550 | 0.67 | — | — | |
| SCHEMBL4018043 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1781633-A1 | NOVEL ANTIDIABETIC COMPOUNDS | CADILA HEALTHCARE LIMITED (IN) | 2007-05-09 | — | — | EP | disclosed |
| WO-2006018855-A1 | NOVEL ANTIDIABETIC COMPOUNDS | CADILA HEALTHCARE LIMITED (IN) | 2006-02-23 | — | — | WO | disclosed |
| WO-2005077937-A1 | SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS TNF INHIBITORS | CADILA HEALTHCARE LIMITED (IN) | 2005-08-25 | — | — | WO | disclosed |
| US-5187214-A | Alkyl benzene sulfonates or alkane sulfonates for applying to or mixing into synthetic polymers | PPG INDUSTRIES, INC. (US) | 1993-02-16 | — | — | US | disclosed |
| US-4904825-A | SALTS OF ALKYLBENZENE OR ALKANE SULFONATES; HEAT RESISTANCE; DECAY; POLYMER NONCONDUCTORS; TEXTILES; FIBERS | PPG INDUSTRIES, INC. (US) | 1990-02-27 | — | — | US | disclosed |